These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23551230)

  • 1. Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer.
    Kubota K; Sato T; Watanabe S; Hosono K; Kobayashi N; Mori R; Taniguchi K; Matsuyama R; Endo I; Nakajima A
    Dig Endosc; 2014 Jan; 26(1):77-86. PubMed ID: 23551230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer.
    Nakamura K; Sho M; Akahori T; Nagai M; Nishiwada S; Nakagawa K; Tanaka T; Kichikawa K; Tamamoto T; Hasegawa M; Mitoro A; Yoshiji H; Ikeda N
    World J Surg; 2019 Feb; 43(2):642-648. PubMed ID: 30298284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study.
    Aadam AA; Evans DB; Khan A; Oh Y; Dua K
    Gastrointest Endosc; 2012 Jul; 76(1):67-75. PubMed ID: 22483859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial protocol: a randomised controlled trial to verify the non-inferiority of a partially covered self-expandable metal stent to an uncovered self-expandable metal stent for biliary drainage during neoadjuvant therapy in patients with pancreatic cancer with obstructive jaundice (PUN-NAC trial).
    Kuwatani M; Kawakubo K; Sugimori K; Inoue H; Kamada H; Ishiwatari H; Kato S; Iwashita T; Yoshida M; Hashimoto S; Itonaga M; Mizukami Y; Nomura Y; Katanuma A; Sakamoto N
    BMJ Open; 2021 Jul; 11(7):e045698. PubMed ID: 34244257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal resection area for superior mesenteric artery nerve plexuses after neoadjuvant chemoradiotherapy for locally advanced pancreatic carcinoma.
    Einama T; Kamachi H; Tsuruga Y; Sakata T; Shibuya K; Sakamoto Y; Shimada S; Wakayama K; Orimo T; Yokoo H; Kamiyama T; Katoh N; Uchinami Y; Mitsuhashi T; Taketomi A
    Medicine (Baltimore); 2018 Aug; 97(31):e11309. PubMed ID: 30075497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covered self-expandable metallic stent versus plastic stent for preoperative endoscopic biliary drainage in patients with pancreatic cancer: a multi-center retrospective cohort study.
    Ichikawa H; Iwashita T; Iwasa Y; Uemura S; Tezuka R; Okuno M; Mukai T; Yoshida K; Maruta A; Iwata K; Murase K; Osada S; Kawai M; Yasuda I; Shimizu M
    Scand J Gastroenterol; 2022 Apr; 57(4):493-500. PubMed ID: 34951833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients.
    Siddiqui AA; Mehendiratta V; Loren D; Kowalski T; Fang J; Hilden K; Adler DG
    Dig Dis Sci; 2013 Jun; 58(6):1744-50. PubMed ID: 23179157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
    Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
    Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer.
    Thanikachalam K; Damarla V; Seixas T; Dobrosotskaya I; Wollner I; Kwon D; Winters K; Raoufi M; Li J; Siddiqui F; Khan G
    Am J Clin Oncol; 2020 Jun; 43(6):435-441. PubMed ID: 32251119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of metal vs plastic stents for biliary obstruction in patients with pancreatic carcinoma undergoing neoadjuvant chemoradiotherapy: A systematic review and meta-analysis.
    Kumar N; Jena A; Sharma V; Shukla S; Shah J
    J Hepatobiliary Pancreat Sci; 2023 Apr; 30(4):419-428. PubMed ID: 36106923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Biliary Drainage during a Neoadjuvant Therapy for Pancreatic Cancer: Metal versus Plastic Stents.
    Kuwatani M; Nakamura T; Hayashi T; Kimura Y; Ono M; Motoya M; Imai K; Yamakita K; Goto T; Takahashi K; Maguchi H; Hirano S;
    Gut Liver; 2020 Mar; 14(2):269-273. PubMed ID: 31060118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.
    Sho M; Akahori T; Tanaka T; Kinoshita S; Nagai M; Nishiwada S; Tamamoto T; Nishiofuku H; Ohbayashi C; Hasegawa M; Kichikawa K; Nakajima Y
    Langenbecks Arch Surg; 2015 May; 400(4):477-85. PubMed ID: 25929828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.
    Nagakawa Y; Sahara Y; Hosokawa Y; Murakami Y; Yamaue H; Satoi S; Unno M; Isaji S; Endo I; Sho M; Fujii T; Takishita C; Hijikata Y; Suzuki S; Kawachi S; Katsumata K; Ohta T; Nagakawa T; Tsuchida A
    Ann Surg Oncol; 2019 Jun; 26(6):1629-1636. PubMed ID: 30610555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covered self-expandable metal stents versus plastic stents for preoperative biliary drainage in patient receiving neo-adjuvant chemotherapy for borderline resectable pancreatic cancer: Prospective randomized study.
    Tamura T; Itonaga M; Ashida R; Yamashita Y; Hatamaru K; Kawaji Y; Emori T; Kitahata Y; Miyazawa M; Hirono S; Okada KI; Kawai M; Shimokawa T; Yamaue H; Kitano M
    Dig Endosc; 2021 Nov; 33(7):1170-1178. PubMed ID: 33410564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer.
    Satoi S; Toyokawa H; Yanagimoto H; Yamamoto T; Kamata M; Ohe C; Sakaida N; Uemura Y; Kitade H; Tanigawa N; Inoue K; Matsui Y; Kwon AH
    J Gastrointest Surg; 2012 Apr; 16(4):784-92. PubMed ID: 22160780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting.
    Fujii T; Satoi S; Yamada S; Murotani K; Yanagimoto H; Takami H; Yamamoto T; Kanda M; Yamaki S; Hirooka S; Kon M; Kodera Y
    J Gastroenterol; 2017 Jan; 52(1):81-93. PubMed ID: 27169844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Analyses of hENT1, TS, and DPD Predict Outcomes of Borderline-resectable Pancreatic Cancer.
    Yabushita Y; Mori R; Taniguchi K; Matsuyama R; Kumamoto T; Sakamaki K; Kubota K; Endo I
    Anticancer Res; 2017 May; 37(5):2465-2476. PubMed ID: 28476815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified non-flared fully covered self-expandable metal stent for preoperative biliary drainage in pancreatic cancer.
    Shin IS; Moon JH; Lee YN; Chung JC; Jeong J; Choi SY; Lee TH; Yang JK; Cha SW; Cho YD; Park SH
    J Gastroenterol Hepatol; 2022 Jan; 37(1):225-232. PubMed ID: 34750863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement.
    Nagakawa Y; Hosokawa Y; Nakayama H; Sahara Y; Takishita C; Nakajima T; Hijikata Y; Kasuya K; Katsumata K; Tokuuye K; Tsuchida A
    Cancer Chemother Pharmacol; 2017 May; 79(5):951-957. PubMed ID: 28378027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01).
    Hayashi T; Nakamura T; Kimura Y; Yoshida M; Someya M; Kawakami H; Sakuhara Y; Katoh N; Takahashi K; Ambo Y; Miura K; Motoya M; Tanaka E; Murakawa K; Yamabuki T; Yamazaki H; Katanuma A; Hirano S;
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):606-617. PubMed ID: 31306735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.